Howard Capital Management Inc.

Position in JNJ — Johnson & Johnson

CIK 1733173 ROSWELL, GA

Position in JNJ

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$5,009,558

+$2,663,423 QoQ

Shares Held

19,725

+105.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,617

of 4,676 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Howard Capital Management Inc. holds $46,726,837 across 9 Drug Manufacturers - General names. JNJ ranks #4 (10.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	7,165	$8,593,916
2	ABBV	AbbVie Inc.	32,751	$8,241,461
3	AMGN	Amgen Inc	21,489	$7,781,596
4	JNJ	Johnson & Johnson This page	19,725	$5,009,558
5	GILD	Gilead Sciences, Inc.	39,385	$4,975,900
6	PFE	Pfizer Inc	193,027	$4,648,090
7	BMY	Bristol Myers Squibb Co	46,206	$2,662,389
8	OGN	Organon & Co.	178,927	$2,422,671

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,009,558	19,725	+105.5%	Shares	Sole	2026-07-28
2026-03-31	$2,346,135	9,598	-49.2%	Shares	Sole	2026-05-05
2025-12-31	$3,911,975	18,903	+0.5%	Shares	Sole	2026-01-23
2025-09-30	$3,486,452	18,803	+3.3%	Shares	Sole	2025-11-04
2025-06-30	$2,780,508	18,203	+10.3%	Shares	Sole	2025-08-01
2025-03-31	$2,738,018	16,510	-12.5%	Shares	Sole	2025-05-08
2024-12-31	$2,730,280	18,879	+5.8%	Shares	Sole	2025-02-04
2024-09-30	$2,892,771	17,850	+1370.3%	Shares	Sole	2024-11-12
2023-06-30	$200,941	1,214	-49.1%	Shares	Sole	2023-08-03
2022-12-31	$421,486	2,386	+6.1%	Shares	Sole	2023-01-30
2022-09-30	$367,233	2,248	-9.2%	Shares	Sole	2022-11-04
2022-06-30	$439,692	2,477	+2.7%	Shares	Sole	2022-07-27
2022-03-31	$427,655	2,413	+6.4%	Shares	Sole	2022-05-02
2021-12-31	$387,986	2,268	—	Shares	Sole	2022-01-31
No filing history on record for this holder in this stock.